AdaptHealth (AHCO) EBITDA Margin (2019 - 2026)
AdaptHealth's (AHCO) quarterly EBITDA Margin came in at 0.67% in Q1 2026, down 231.0% year-on-year from 0.51% in Q1 2025, and up 107.73% quarter-over-quarter from 8.66% in Q4 2025.
AdaptHealth (AHCO) EBITDA Margin (2019 - 2026) Analysis & Trends
AdaptHealth's EBITDA Margin history runs 8 years deep, the most recent figure standing at 0.67% for Q1 2026.
- On a quarterly basis, EBITDA Margin fell 231.0% year-over-year to 0.67% in Q1 2026; TTM through Mar 2026 was 2.23%, a 505.0% decrease from a year earlier, with the FY2025 full-year figure at 2.8%, down 529.0% from the prior year.
- EBITDA Margin improved to 0.67% in Q1 2026 per AHCO's latest filing, from 8.66% in the prior quarter.
- Across five years, EBITDA Margin topped out at 11.4% in Q4 2024 and bottomed at 57.34% in Q3 2023.
- The 5-year median for EBITDA Margin is 6.46% (2024), against an average of 0.12%.
- Across the five-year window, EBITDA Margin plunged 6434 bps in 2023 and soared 6522 bps in 2024, its largest moves.
- Year by year, EBITDA Margin stood at 3.43% in 2022, then slumped by 841 bps to 25.38% in 2023, then soared by 145 bps to 11.4% in 2024, then slumped by 176 bps to 8.66% in 2025, then jumped by 108 bps to 0.67% in 2026.
- Per Business Quant, the three latest AHCO EBITDA Margin figures stand at 0.67% (Q1 2026), 8.66% (Q4 2025), and 7.53% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AdaptHealth | 1.42 Bn | 1.38 Bn | 111.50 Mn | 0.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.67% |
| Dec 31, 2025 | -8.66% |
| Sep 30, 2025 | 7.53% |
| Jun 30, 2025 | 9.90% |
| Mar 31, 2025 | 2.98% |
| Dec 31, 2024 | 11.40% |
| Sep 30, 2024 | 7.88% |
| Jun 30, 2024 | 6.46% |
| Mar 31, 2024 | 6.38% |
| Dec 31, 2023 | -25.38% |
| Sep 30, 2023 | -57.34% |
| Jun 30, 2023 | 6.84% |
| Mar 31, 2023 | 3.52% |
| Dec 31, 2022 | 3.43% |
| Sep 30, 2022 | 7.00% |
| Jun 30, 2022 | 8.13% |
| Mar 31, 2022 | 7.30% |
| Dec 31, 2021 | 9.84% |
| Sep 30, 2021 | 11.59% |
| Jun 30, 2021 | 10.60% |